-Bloomberg
NeoGenomics Q2 Earnings Helped By Higher Test Volume; Backs FY21 Guidance
NeoGenomics Inc (NASDAQ:NEO) reported Q2 revenue of $122 million, +40% Y/Y, beating the consensus of $118.16 million. Clinical Services revenue…
Related Posts
Stocks That Hit 52-Week Highs On Wednesday
This morning 122 companies reached new 52-week highs.
Microsoft’s October 5 Windows 11 Launch – Everything You Wanted To Know
Microsoft Corp (NASDAQ:MSFT) will start offering free upgrades to Windows 11 to eligible PCs on October 5, the company wrote…
Mark Zuckerberg Confirms NFTs Are Coming Soon To Instagram
Meta Platforms Inc (NASDAQ: FB) CEO Mark Zuckerberg said that the company is working on bringing non fungible tokens (NFTs) to its social media platform, Instagram.